Jacobio (01167) Announces November 2025 Share Repurchase Data

Bulletin Express12-03

Jacobio Pharmaceuticals Group Co., Ltd. (Stock Code: 01167) confirmed that, as of November 30, 2025, its authorized share capital stood unchanged at USD 100,000, comprising 1,000,000,000 ordinary shares at a par value of USD 0.0001. The total number of issued shares remained at 791,755,080, with part of the shares held in treasury.

According to the disclosed report, 481,200 shares were repurchased during November and transferred to treasury shares, reducing the issued shares (excluding treasury shares) from 787,543,980 to 787,062,780. Consequently, treasury shares increased from 4,211,100 to 4,692,300. These share repurchases took place on multiple dates in November at various prices ranging between HKD 6.53 and HKD 7.21.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment